{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T02:05:01Z","timestamp":1745805901357},"reference-count":23,"publisher":"Japanese Society of Internal Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2012]]},"DOI":"10.2169\/internalmedicine.51.7019","type":"journal-article","created":{"date-parts":[[2012,5,31]],"date-time":"2012-05-31T22:54:46Z","timestamp":1338504886000},"page":"1387-1392","source":"Crossref","is-referenced-by-count":8,"title":["A Case of Follicular Lymphoma Associated with Paraneoplastic Cerebellar Degeneration"],"prefix":"10.2169","volume":"51","author":[{"given":"Yayoi","family":"Shimazu","sequence":"first","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiko N.","family":"Minakawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Momoko","family":"Nishikori","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Ihara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Hashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Matsuyama","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakatsu","family":"Hishizawa","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonoyo","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Takashima General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Kitano","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadakazu","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akifumi","family":"Takaori-Kondo","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Vedeler CA, Antoine JC, Giometto B, et al. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force. Eur J Neurol 13: 682-690, 2006."},{"key":"2","unstructured":"2. Graus F, Dalmau J. Paraneoplastic neurological syndromes: diagnosis and treatment. Curr Opin Neurol 20: 732-737, 2007."},{"key":"3","unstructured":"3. Shams'ili S, Grefkens J, de Leeuw B, et al. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 126: 1409-1418, 2003."},{"key":"4","unstructured":"4. Schmitz-Hubsch T, du Montcel ST, Baliko L, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 66: 1717-1720, 2006."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Solal-Celigny P, Roy P, Colombat P, et al. Follicular lymphoma international prognostic index. Blood 104: 1258-1265, 2004.","DOI":"10.1182\/blood-2003-12-4434"},{"key":"6","unstructured":"6. Federico M, Bellei M, Marcheselli L, et al. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. J Clin Oncol 27: 4555-4562, 2009."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med 349: 1543-1554, 2003.","DOI":"10.1056\/NEJMra023009"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75: 1135-1140, 2004.","DOI":"10.1136\/jnnp.2003.034447"},{"key":"9","unstructured":"9. Albert ML, Darnell RB. Paraneoplastic neurological degenerations: keys to tumour immunity. Nat Rev Cancer 4: 36-44, 2004."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Clouston PD, Saper CB, Arbizu T, et al. Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome. Neurology 42: 1944-1950, 1992.","DOI":"10.1212\/WNL.42.10.1944"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Symonds RP, Hogg RB, Bone I. Paraneoplastic neurological syndromes associated with lymphomas. Leuk Lymphoma 15: 487-490, 1994.","DOI":"10.3109\/10428199409049752"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ang LC, Zochodne DW, Ebers GC, Kaufmann JC, Vinters HV. Severe cerebellar degeneration in a patient with T-cell lymphoma. Acta Neuropathol 69: 171-175, 1986.","DOI":"10.1007\/BF00687056"},{"key":"13","unstructured":"13. Ishihara K, Suzuki Y, Shiota J, Kawamura M, Nakano I. An autopsied case of paraneoplastic neurologic syndrome (limbic encephalitis, cerebellar degeneration, and pseudohypertrophy in the inferior olivary nuclei) associated with T cell lymphoma. Rinsho Shinkeigaku 45: 583-589, 2005 (in Japanese, Abstract in English)."},{"key":"14","unstructured":"14. Rodis DG, Liatsos GD, Moulakakis A, Pirounaki M, Tasidou A. Paraneoplastic cerebellar degeneration: initial presentation in a patient with anaplastic T-cell lymphoma, associated with ichthyosiform cutaneous lesions. Leuk Lymphoma 50: 1369-1371, 2009."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Razzak A, Shields M, Allsup D. Autoimmune paraneoplastic cerebellar degeneration secondary to a composite lymphoma. Leuk Lymphoma 48: 1456-1458, 2007.","DOI":"10.1080\/10428190701387047"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Tanaka K, Yamazaki M, Sato S, Toyoshima I, Yamamoto A, Miyatake T. Antibodies to brain proteins in paraneoplastic cerebellar degeneration. Neurology 36: 1169-1172, 1986.","DOI":"10.1212\/WNL.36.9.1169"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Hammack J, Kotanides H, Rosenblum MK, Posner JB. Paraneoplastic cerebellar degeneration. II. Clinical and immunologic findings in 21 patients with Hodgkin's disease. Neurology 42: 1938-1943, 1992.","DOI":"10.1212\/WNL.42.10.1938"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Bernal F, Shams'ili S, Rojas I, et al. Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease. Neurology 60: 230-234, 2003.","DOI":"10.1212\/01.WNL.0000041495.87539.98"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Roberts WK, Darnell RB. Neuroimmunology of the paraneoplastic neurological degenerations. Curr Opin Immunol 16: 616-622, 2004.","DOI":"10.1016\/j.coi.2004.07.009"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. Lancet Neurol 7: 327-340, 2008.","DOI":"10.1016\/S1474-4422(08)70060-7"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Graus F, Saiz A, Dalmau J. Antibodies and neuronal autoimmune disorders of the CNS. J Neurol 257: 509-517, 2010.","DOI":"10.1007\/s00415-009-5431-9"},{"key":"22","unstructured":"22. Voltz R. Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy. Lancet Neurol 1: 294-305, 2002."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Shams'ili S, de Beukelaar J, Gratama JW, et al. An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes. J Neurol 253: 16-20, 2006.","DOI":"10.1007\/s00415-005-0882-0"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/51\/11\/51_51.7019\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:43:16Z","timestamp":1621446196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/51\/11\/51_51.7019\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.51.7019","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}